An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?

• Main Authors: Parkinson Lynne (Author), Doljagore Xenia (Author), Gibson Richard (Author), Doran Evan (Author), Notley Lisa (Author), Stewart Williams Jenny (Author), Kowal Paul (Author), Byles Julie E (Author)
• Format: Book
• Published: BMC, 2011-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>When a medicine such as rofecoxib (Vioxx) is withdrawn, or a whole class of medicines discredited such as the selective COX-2 inhibitors (COX-2s), follow-up of impacts at consumer level can be difficult and costly. The Australian Lon...